on-invasive combination therapy of IPL and RF in acne inversa (NICE)

Not Applicable

• Conditions: Acne inversa; L73.2; Hidradenitis suppurativa

• Registration Number: DRKS00014017
• Lead Sponsor: Dermatologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-10-31
• Study Start: 2018-02-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 47

Inclusion Criteria

Acne inversa since longer than 6 months before study
- at least 3 clinically visible abscesses or noduli
- informed consent for study participation

Exclusion Criteria

- Malignant Tumors
- concomitant systemic or topical treatment with immunomodulatory agents, antibiotics, retinoids, etc. /exceptions: transient acute treatment due to acute abscess, local antiseptics, local adminitration of ichthyol
- pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in active lesion count assessed after observation period (12 weeks), then again after 12 weeks for treatment and after 24 weeks of treatment

Secondary Outcome Measures

Name	Time	Method
Change in DLQI assessed after observation period (12 weeks), then again after 12 weeks for treatment and after 24 weeks of treatment